Sort
15,842 grants matching “pancreatic cancer”
Biological Models, Molecular Pathology and Biostatistics
$155,211Guillermo J. Tearney · Massachusetts General Hospital · P01 · FY2009 · CA
Structure Based Discovery of AKT Inhibitors
$155,200Georgetown University · R21 · FY2003 · CA
Structure Based Discovery of AKT Inhibitors
$155,200Georgetown University · R21 · FY2002 · CA
Selective sensitization of pancreatic tumor cells to chemotherapy
$155,180Erasmus Schneider · Wadsworth Center · R21 · FY2010 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2019 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2021 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2023 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2020 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2022 · CA
Proteomics Shared Resource
$155,039Daniel Jon McCormick · Mayo Clinic Rochester · P30 · FY2019 · CA
SGER: Development of Minimally Invasive Optical Technique for Early Detection of Pancreatic Cancer
$155,000Vadim Backman · Northwestern University · · FY2004 · ENG
Core C-Computational Core
$154,998Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
Mouse model of adult-onset, isolated, GH-deficiency
$154,980Rhonda D. Kineman · University Of Illinois At Chicago · R21 · FY2008 · AG
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
$154,908William Richard McCombie · Cold Spring Harbor Laboratory · P20 · FY2017 · CA
Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome
$154,758Jeffrey Zwicker · Beth Israel Deaconess Medical Center · K23 · FY2009 · HL
Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome
$154,758Jeffrey Zwicker · Beth Israel Deaconess Medical Center · K23 · FY2011 · HL
Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome
$154,758Jeffrey Zwicker · Beth Israel Deaconess Medical Center · K23 · FY2010 · HL
Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome
$154,758Jeffrey Zwicker · Beth Israel Deaconess Medical Center · K23 · FY2008 · HL
CXCR2-Dependent Pancreatic Cancer Progression and Metastasis
$154,630Rakesh K Singh · University Of Nebraska Medical Center · U54 · FY2013 · CA
Inferring the roots of metastases and their effects on patient survival
$154,629Johannes G Reiter · Stanford University · K99 · FY2018 · CA
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
$154,589William Richard McCombie · Cold Spring Harbor Laboratory · P20 · FY2018 · CA
ACTIVATION OF C SRC IN PANCREATIC CANCER BY FGFR 1B
$154,584University Of Alabama At Birmingham · K01 · FY2001 · CA
ACTIVATION OF C SRC IN PANCREATIC CANCER BY FGFR 1B
$154,584University Of Alabama At Birmingham · K01 · FY2003 · CA
Targeting LIF/LIFR in pancreatic cancer
$154,566Hareesh Babu Nair · Evestra, Inc. · R44 · FY2019 · CA
Novel Anti-HER3 Strategy for Pancreatic Cancer
$154,540Tong Zhou · University Of Alabama At Birmingham · R21 · FY2014 · CA